Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Xconomy: Vividion Raises $82M To Advance Small Molecule Drugs To The Clinic
Venture Capital

Xconomy: Vividion Raises $82M To Advance Small Molecule Drugs To The Clinic

by xconomy.com posted 3weeks ago 10 views
Vividion Therapeutics, a biotechnology company that launched in 2017 around discoveries made in Scripps Research Institute labs, has raised $82 million in financing. Nextech Invest, a Swiss investment firm that funds companies developing cancer therapeutics, led the Series B round of funding. As part of the investment, Nextech partner Jakob Loven gets a board seat. […]

In this article